These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 36609599)

  • 1. O-GlcNAcylation promotes the progression of nonalcoholic fatty liver disease by upregulating the expression and function of CD36.
    Zhu H; Zhao T; Zhao S; Yang S; Jiang K; Li S; Kang Y; Yang Z; Shen J; Shen S; Tao H; Xuan J; Yang M; Xu B; Wang F; Jiang M
    Metabolism; 2024 Jul; 156():155914. PubMed ID: 38642829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic loss of CD36 aggravates NAFLD-related HCC through MEK1/2-ERK1/2 signaling pathway.
    Zheng E; Chen Q; Xiao A; Luo X; Lu Q; Tian C; Liu H; Zhao J; Wei L; Yang P; Chen Y
    Biochem Biophys Res Commun; 2024 May; 707():149781. PubMed ID: 38492244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic DKK1-driven steatosis is CD36 dependent.
    Yang Z; Huang X; Zhang J; You K; Xiong Y; Fang J; Getachew A; Cheng Z; Yu X; Wang Y; Wu F; Wang N; Feng S; Lin X; Yang F; Chen Y; Wei H; Li YX
    Life Sci Alliance; 2023 Jan; 6(1):. PubMed ID: 36410795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abrogation of GH action in Kupffer cells results in increased hepatic CD36 expression and exaggerated nonalcoholic fatty liver disease.
    Zhang S; Lu C; Das AK; Pasupulati AK; Menon RK
    Growth Horm IGF Res; 2018; 42-43():74-79. PubMed ID: 30321786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypermethylation of Klotho and Peroxisome Proliferator-Activated Receptor γ Concomitant with Overexpression of DNA Methyltransferase 1 in Adenomyosis.
    Fan J; Liu X; Guo SW
    Reprod Sci; 2024 May; ():. PubMed ID: 38816595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the relationship between histone methylation and nonalcoholic fatty liver disease.
    Xu L; Fan YH; Zhang XJ; Bai L
    World J Hepatol; 2024 May; 16(5):703-715. PubMed ID: 38818286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intervening TNF-α via PPARγ with Gegenqinlian Decoction in Experimental Nonalcoholic Fatty Liver Disease.
    Wang YL; Liu LJ; Zhao WH; Li JX
    Evid Based Complement Alternat Med; 2015; 2015():715638. PubMed ID: 26221176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell CD36 regulates membrane ceramide formation, exosome fatty acid transfer and circulating fatty acid levels.
    Peche VS; Pietka TA; Jacome-Sosa M; Samovski D; Palacios H; Chatterjee-Basu G; Dudley AC; Beatty W; Meyer GA; Goldberg IJ; Abumrad NA
    Nat Commun; 2023 Jul; 14(1):4029. PubMed ID: 37419919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of phospholipase D1 ameliorates hepatocyte steatosis and non-alcoholic fatty liver disease.
    Wang H; Zhao Y; Pan Y; Yang A; Li C; Wang S; Dong Z; Li M; Wang S; Zhang Z; Zhu Y; Zhang D; Sun G
    JHEP Rep; 2023 Jun; 5(6):100726. PubMed ID: 37138676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleic acid improves hepatic lipotoxicity injury by alleviating autophagy dysfunction.
    Liu X; Li X; Su S; Yuan Y; Liu W; Zhu M; Zheng Q; Zeng X; Fu F; Lu Y; Chen Y
    Exp Cell Res; 2023 Aug; 429(2):113655. PubMed ID: 37253404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological inhibition of DNMT1 restores macrophage autophagy and M2 polarization in Western diet-induced nonalcoholic fatty liver disease.
    Pant R; Kabeer SW; Sharma S; Kumar V; Patra D; Pal D; Tikoo K
    J Biol Chem; 2023 Jun; 299(6):104779. PubMed ID: 37142224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbelliferone Ameliorates Hepatic Steatosis and Lipid-Induced ER Stress in High-Fat Diet-Induced Obese Mice.
    Park NW; Lee ES; Ha KB; Jo SH; Kim HM; Kwon MH; Chung CH
    Yonsei Med J; 2023 Apr; 64(4):243-250. PubMed ID: 36996895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mini review: STING activation during non-alcoholic fatty liver disease.
    Li H; Guo X; Aquino E; Wu C
    Front Nutr; 2023; 10():1139339. PubMed ID: 36937350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TET2 regulation of alcoholic fatty liver via
    Li Q; Pan Y; Zhang J; Hu B; Qin D; Liu S; Chen N; Zhang L
    iScience; 2024 Mar; 27(3):109278. PubMed ID: 38482502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guanylate-binding proteins signature predicts favorable prognosis, immune-hot microenvironment, and immunotherapy response in hepatocellular carcinoma.
    Ning Y; Fang S; Fang J; Lin K; Nie H; Xiong P; Qiu P; Zhao Q; Wang H; Wang F
    Cancer Med; 2023 Aug; 12(16):17504-17521. PubMed ID: 37551111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome Proliferator-Activated Receptor-γ as a Target and Regulator of Epigenetic Mechanisms in Nonalcoholic Fatty Liver Disease.
    Zaiou M
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Regulations in Mammalian Cells: Roles and Profiling Techniques.
    Kim U; Lee DS
    Mol Cells; 2023 Feb; 46(2):86-98. PubMed ID: 36859473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dnmt1/Tet2-mediated changes in Cmip methylation regulate the development of nonalcoholic fatty liver disease by controlling the Gbp2-Pparγ-CD36 axis.
    Lee J; Song JH; Park JH; Chung MY; Lee SH; Jeon SB; Park SH; Hwang JT; Choi HK
    Exp Mol Med; 2023 Jan; 55(1):143-157. PubMed ID: 36609599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of Peroxisome Proliferator-Activated Receptor Gamma Mediates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease.
    Hajri T; Zaiou M; Fungwe TV; Ouguerram K; Besong S
    Cells; 2021 May; 10(6):. PubMed ID: 34072832
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.